OCTAVE SPECIALTY GROUP INC (OSG)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150M 300M 450M Q3 '21: 317M Q4 '21: 282M Q1 '22: 272M Q2 '22: 309M Q3 '22: 338M Q4 '22: 293.7M Q1 '23: 232.7M Q2 '23: 208.7M Q3 '23: 202.7M Q4 '23: 206.3M Q1 '24: 197.8M Q2 '24: 186.9M Q3 '24: 182.9M Q4 '24: 235.8M Q1 '25: 249M Q2 '25: 252.9M Q3 '25: 249.5M Q4 '25: 251.2M Q1 '26: 292.6M Q2 '26: 320.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

-900M -600M -300M 0 300M 600M 900M Q3 '21: -9M Q4 '21: -17M Q1 '22: -32M Q2 '22: 2M Q3 '22: 325M Q4 '22: 522.1M Q1 '23: 487.1M Q2 '23: 469.1M Q3 '23: 195.1M Q4 '23: 4.3M Q1 '24: 58.1M Q2 '24: 70.3M Q3 '24: -23.2M Q4 '24: -555.7M Q1 '25: -622.9M Q2 '25: -695.1M Q3 '25: -780.2M Q4 '25: -259.3M Q1 '26: -219.8M Q2 '26: -159M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-500M 0 500M 1B 1.5B Q3 '20: -182M Q4 '20: -175M Q1 '21: -128M Q2 '21: -146M Q3 '21: -144M Q4 '21: -131M Q1 '22: -82M Q2 '22: -37M Q3 '22: 64M Q4 '22: 1.3B Q1 '23: 1.4B Q2 '23: 1.4B Q3 '23: 1.4B Q4 '23: 200M Q1 '24: 130.1M Q2 '24: 126.5M Q3 '24: 164.4M Q4 '25: -52.3M Q1 '26: -49.8M Q2 '26: -62.1M Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 46.1M Q2 '20: 46.2M Q3 '20: 46.2M Q1 '21: 46.9M Q2 '21: 46.6M Q3 '21: 47M Q1 '22: 47.4M Q2 '22: 45.7M Q3 '22: 45.8M Q1 '23: 45.6M Q2 '23: 45.8M Q3 '23: 46.8M Q1 '24: 45.8M Q2 '24: 46.2M Q3 '24: 47.7M Q1 '25: 47.3M Q2 '25: 48.1M Q3 '25: 48.1M Q1 '26: 45.3M Q2 '26: 45.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q3 '20: -11.57 Q4 '20: -9.48 Q1 '22: -0.66 Q2 '22: 0.08 Q3 '22: 7.14 Q4 '22: 11.56 Q1 '23: 10.79 Q2 '23: 10.39 Q3 '23: 4.39 Q4 '23: 0.15 Q1 '24: 1.32 Q2 '24: 1.59 Q3 '24: -0.45 Q4 '24: -10.44 Q1 '25: -12.09 Q2 '25: -13.58 Q3 '25: -15.30 Q4 '25: -5.89 Q1 '26: -4.81 Q2 '26: -3.63 Q4 '20 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.